Abstract
Objectives: to investigate the contribution of vascular endothelial growth factor (VEGF) variants 2578 C/A (rs699947) to vaso-occlusive crisis (VOC) pathogenesis in sickle cell disease (SCD) patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have